A single incidence of whole-genome doubling (WGD) is common early in tumorigenesis.
Introduction
Most human tumors are aneuploid. In about one-third of tumors, aneuploidy is preceded by a whole-genome doubling (WGD) (Zack et al., 2013) , an event that correlates with poor prognosis for patients (Bielski et al., 2018) . After WGD, the newly tetraploid genome promotes the evolution of aneuploid karyotypes (Dewhurst et al., 2014) , with tumor cells losing chromosomes and acquiring chromosomal rearrangements (Carter et al., 2012; Zack et al., 2013) . However, WGD can be detrimental to subsequent mitoses because centrosome number doubles (from 2 to 4) concomitantly with genome doubling. Because each centrosome nucleates microtubules during mitosis (Ring et al., 1982) , a multipolar spindle forms, which can result in a lethal multipolar cell division (Ganem et al., 2009 ). Centrosome amplification is nevertheless common in cancers (Chan, 2011) because cells can cluster supernumerary centrosomes into a pseudobipolar spindle (Quintyne et al., 2005) . Because lethal multipolar cell divisions are expected to decrease the fitness of a tumor cell population, cancer cells likely experience selective pressures to efficiently cluster supernumerary centrosomes.
Centrosome clustering occurs via motor proteins located near spindle poles and centrosomes, such as dynein and KIFC1/HSET, as well as proteins localized at the kinetochore/centromere that control microtubule binding and spindle assembly checkpoint signaling (Drosopoulos et al., 2014; Kwon et al., 2008; Leber et al., 2010; Quintyne et al., 2005) . At the cell cortex, motor proteins associated with the cortical actin network, such as Myo10 and dynein, position centrosomes through contacts with astral microtubules (Kwon et al., 2015; Quintyne et al., 2005) . These proteins contribute to spindle assembly and placement in cells with two centrosomes, suggesting that centrosome clustering occurs through normal cellular pathways. However, centrosome clustering is more efficient in cancer cells compared to non-transformed cells (Ganem et al., 2009) . Centrosome clustering efficiency can be increased by depletion of the microtubule binding protein NUMA (Quintyne et al., 2005) or the adhesion protein Ecadherin (Rhys et al., 2018) . However, it remains largely unclear how cancer cells evolve to cluster centrosomes more proficiently.
Genomic analyses have identified genetic alterations that positively correlate with WGD (Bielski et al., 2018; Zack et al., 2013) . Several changes (TP53 and RB1 mutation, CCNE1 amplification) enable cell proliferation after WGD by weakening the G1 arrest triggered following cytokinesis failure (Andreassen et al., 2001) . The molecular impact of other genetic changes associated with WGD, including alterations in protein phosphatase 2A (PP2A), is not known. PP2A is a major source of serine/threonine phosphatase activity and is involved in many cellular processes (Wlodarchak and Xing, 2016) . PP2A substrate selectivity arises through protein-protein interactions. In the PP2A heterotrimer, a catalytic subunit (PP2A-Cα/β) and a 'scaffolding' subunit (PP2A-Aα/β) are targeted to substrates by families of regulatory subunits. PP2A inactivation was first linked to tumorigenesis when it was discovered that SV40 small t antigen blocks the binding of PP2A-Aα/β to regulatory subunits (Pallas et al., 1990) , leading to cellular transformation (Chen et al., 2004) . Potentially similar perturbations have been found in tumors, including homozygous deletion of PPP2R2A, which encodes the B55α regulatory subunit, and heterozygous missense mutations in PPP2R1A, which encodes the α isoform PP2A-A that accounts for ~90% of total PP2A-A (Zhou et al., 2003) .
Hotspot mutations in PP2A-Aα are expected to prevent B55 and B56 regulatory subunit binding (Cho and Xu, 2007; Xu et al., 2006; Xu et al., 2008) and likely decrease the functionality of PP2A-Aα. While the impact of PP2A-Aα missense mutations after WGD has not been examined, over-expression of hotspot PP2A-Aα mutants in tissue culture cells has been observed to alter phospho-signaling in other cellular contexts, suggesting the mutations may possibly confer new functions (Haesen et al., 2016; Jeong et al., 2016) .
Here, we examine two prevalent hotspot mutations in PPP2R1A, P179R and R183W.
We find that both mutations reduce PP2A protein-protein interactions. When introduced into one allele of endogenous PPP2R1A, the P179R mutation reduces PP2A holoenzyme assembly and intracellular targeting. Strikingly, we find that these changes are sufficient to increase centrosome clustering, in part through factors at the cell cortex that position centrosomes.
Results

Characterization of prevalent cancer-associated PP2A-Aα missense mutations
PPP2R1A is most frequently mutated in uterine carcinosarcomas (Fig. 1A) . To explore the cellular impact of the two most frequent PPP2R1A missense mutations ( Fig. 1B) , we generated retinal pigment epithelial (RPE-1) hTERT cell lines expressing GFP-tagged PP2A-Aα wild type (WT), P179R, or R183W mutants. Each construct was expressed at 30-40% of the level of endogenous PP2A-Aα/β (Fig. 1C ). Using quantitative mass spectrometry, we compared the composition of PP2A complexes isolated from SILAC labeled cells by immunoprecipitation of WT or mutant GFP-PP2A-Aα. We focused on proteins with > 2-fold change in binding and P < 0.05 (two-sample t-test). The P179R mutation significantly reduced PP2A-Aα binding to four B56 regulatory subunits (B56α/PPP2R5A, B56β/PPP2R5B, B56δ/PPP2R5D and B56ε/PPP2R5E). Accordingly, the binding of proteins that associate with PP2A-Aα via B56 subunits including GEF-H1 (ARHGEF2), Liprinα1 (PPFIA1) (Hertz et al., 2016), and MTCL1 (Hyodo et al., 2016) was similarly reduced (Fig. 1D ). The P179R mutation also significantly reduced binding to the B55δ/PPP2R2D regulatory subunit (Fig. 1D ). The binding of STRN regulatory subunits (STRN, STRN3, and STRN4), a B''' regulatory subunit (PPP2R3A), and PP2A-C (PPP2CA, PPP2CB) was unaffected ( Fig. 1D ). The R183W mutant had an overall similar decrease in protein-protein interactions ( Fig. 1E ). While several proteins were observed to have increased binding to a PP2A-Aα mutant, none were shared between the two mutants ( Fig. 1F ). Thus, the major impact of both the P179R and R183W mutations is to reduce protein-protein interactions.
A heterozygous P179R mutation in PP2A-Aα impacts PP2A holoenzyme assembly in human cells
We next introduced a P179R mutation into one allele of endogenous PPP2R1A in RPE-1 cells. This mutation was selected because it is the most common PP2A-Aα missense mutation in uterine tumors, which have the highest incidence of PP2A-Aα alterations ( Fig. 1A) (Cerami et al., 2012) . We used adeno-associated virus-mediated gene targeting (Berdougo et al., 2009) to introduce a C to G mutation in exon five of PPP2R1A ( Fig. 2A ). We isolated two independent heterozygous clones ( Fig. 2B ). The mutation did not alter the levels of PP2A-Aα or PP2A-Aα/β ( Fig. 2C) . Similarly, PP2A-Aα immunoprecipitates from WT and PP2A-Aα P179R/+ cells had equivalent levels of PP2A-C ( Fig. S1A ) and phosphatase activity ( Fig. S1B ). By contrast, we observed near 2-fold reductions in PP2A-Aα association with B56γ, δ, and ε ( Fig. 2D-2E ) and B55α ( Fig. S1C-D) . Consistent with this reduction, mitotic targeting of PP2A B56 to the kinetochore/centromere was reduced in PP2A-Aα P179R/+ cells ( Fig. 2F-G) . Collectively, these results indicate that a heterozygous P179R mutation in PP2A-Aα is sufficient to alter the level of a subset of PP2A holoenzymes.
PP2A-Aα P179R/+ cells suppress multipolar cell division after cytokinesis failure
To determine if the reduction in PP2A holoenzyme levels might impact PP2A-Aα P179R/+ cells after WGD, we induced one round of cytokinesis failure (Yang et al., 2008) by treating cells with cytochalasin D or B, inhibitors of actin polymerization (Cooper, 1987) , or with blebbistatin, a myosin II inhibitor (Straight et al., 2003) . Binucleate cells were imaged live during the ensuing mitosis ( Fig. 3A ). In this assay, cytokinesis failure triggers p53 activation causing a G1 cell cycle arrest (Andreassen et al., 2001) . Therefore, we treated Tp53 +/+ cells with p38 inhibitor SB 203580 (Cuenda et al., 1995) or utilized Tp53 -/cells. 30% of WT cells treated with cytochalasin D underwent multipolar cell divisions. Strikingly, PP2A-Aα P179R/+ cells exhibited 4-fold reduction in the frequency of multipolar cell divisions compared to WT cells (7% in clone a and 8% in clone b) ( Fig. 3B-C ). PP2A-Aα P179R/+ cells also underwent fewer multipolar cell divisions when cytokinesis failure was induced with cytochalasin B or blebbistatin ( Fig. 3C) .
Similar results were observed in Tp53 -/-PP2A-Aα P179R/+ cells ( Fig. 3D ). Expression of GFP-PP2A-Aα-WT, but not the P179R mutant, in PP2A-Aα P179R/+ cells partially rescued the cell division phenotype. Expression of PP2A-Aα-P179R in WT cells had no impact on the outcome of cell division ( Fig. 3E-F) . These data suggest that enhanced bipolar cell division after WGD in PP2A-Aα P179R/+ cells is likely due to haploinsufficiency.
PP2A-Aα P179R/+ cells have a modest delay in mitosis (22 min in clone a and 21 min in clone b versus 18 min in WT cells) ( Fig. S2A ). Because increased time spent in mitosis suppresses multipolar mitoses (Kwon et al., 2008) , we compared the mitotic duration of binucleate cells that underwent a bipolar cell division. WT and PP2A-Aα P179R/+ cells completed mitosis with indistinguishable kinetics (Fig. 3G ) suggesting that the cell division phenotype of PP2A-Aα P179R/+ cells is likely due to enhanced bipolar spindle assembly in the presence of extra centrosomes, rather than increased time spent in mitosis.
PP2A-Aα P179R/+ cells cluster supernumerary centrosomes more efficiently
In Drosophila, excess centrosomes are sometimes inactivated (Basto et al., 2008) . To examine this possibility in PP2A-Aα P179R/+ cells, we performed the cytokinesis failure assay and then transiently depolymerized microtubules with nocodazole. After allowing a brief time for microtubule re-growth, we fixed the cells. Microtubules were observed at all centrosomes in all mitotic cells examined ( Fig. 4A ). Next, we performed the cytokinesis failure assay and identified anaphases with four centrosomes in fixed cells.
In PP2A-Aα P179R/+ cells, centrosomes were always associated with spindle poles ( Fig.   4B ) and furthermore, were more likely to be clustered ( Fig. 4C ).
To test the hypothesis that PP2A-Aα P179R/+ cells may cluster supernumerary centrosomes more efficiently than WT cells, centrosome amplification was induced by over-expression of Plk4 kinase (Kleylein-Sohn et al., 2007; Peel et al., 2007) (Fig. 4D ).
This increases centrosome number without altering ploidy. We introduced doxycyclineinducible Plk4 into Tp53 -/-WT and PP2A-Aα P179R/+ cells. After doxycycline induction immunofluorescence analyses of C-Nap1, a marker of functional centrioles (Wang et al., 2011) , indicated that 64% of WT cells and 68% of PP2A-Aα P179R/+ cells had centrosome amplification ( Fig. S2B -C). We then analyzed anaphases of cells with extra centrosomes by immunofluorescence ( Fig. 4E ). Strikingly, PP2A-Aα P179R/+ cells had a 6fold reduction in multipolar anaphases compared to WT cells ( Fig. 4F ). A similar result was observed by live imaging (Fig. 4G-H) , with no delay in mitosis ( Fig. 4I ). Additionally, ten minutes prior to anaphase, PP2A-Aα P179R/+ cells exhibited a 6-fold reduction in multipolar chromatin configurations ( Fig. 4J ), suggesting that bipolar spindle geometry is established in advance of anaphase.
Positioning of centrosomes by cortical forces is enhanced in PP2A-Aα P179R/+ cells
To examine how PP2A-Aα P179R/+ cells more efficiently cluster centrosomes, we asked if microtubule organization in mitosis is more robust in PP2A-Aα P179R/+ cells. Although centrosomes are the major sites of microtubule nucleation, a bipolar spindle can assemble in the absence of one or both centrosomes, albeit with some delay (Khodjakov et al., 2000) . We therefore generated acentrosomal cells using centrinone, a small molecule inhibitor of Plk4 (Wong et al., 2015) . After centrinone treatment, > 95% of cells had either one or zero centrosomes ( Fig. 5A-B ). We imaged cells ( Fig. 5C ) and measured the time between nuclear envelope breakdown and anaphase onset. WT and PP2A-Aα P179R/+ cells were similarly delayed upon centrinone treatment ( Fig. 5D) indicating that PP2A-Aα P179R/+ cells are not more robust at spindle assembly in the absence of centrosomes.
Centrosome clustering is a multi-step process (Rhys et al., 2018) . In the first step, contacts between the actin network at the cell cortex and astral microtubules limit centrosome movement (Théry et al., 2005) . To examine the cortical forces acting on centrosomes we plated cells on L-shaped fibronectin micro-patterns. Cortical forces, emanating from retraction fibers at the tips of the "L" shape, position the cell division axis along the hypotenuse of the 'L' (Fig. 5E-F ). In 47% of WT cells, the orientation of the cell division axis was within 30 degrees of the hypotenuse. PP2A-Aα P179R/+ cells exhibited a similar proficiency to align the cell division axis (Fig. 5G ) suggesting that centrosome positioning by cortical forces is similar in WT and PP2A-Aα P179R/+ cells.
To compare the impact of cortical forces in cells with centrosome amplification, we induced centrosome amplification by Plk4 overexpression and plated cells onto O-or Yshaped fibronectin micro-patterns ( Fig. 5H ). Both shapes bias cells with supernumerary centrosomes towards multipolar cell divisions (Kwon et al., 2008) . Indeed, in WT cells these patterns resulted in a 61% and 68% increase in the frequency of multipolar cell divisions on O-and Y-shaped patterns respectively ( Fig. 5I ). Interestingly, in PP2A-Aα P179R/+ cells the frequency of multipolar cell divisions was increased by 144% and 277% on O-and Y-shaped patterns respectively ( Fig. 5I ). Thus, centrosome clustering efficiency in PP2A-Aα P179R/+ cells is more sensitive to interphase cell shape. However, the frequency of multipolar cell divisions in PP2A-Aα P179R/+ cells was still reduced compared to WT cells (Fig. 5I ). This result indicates that while cortical forces contribute to enhanced centrosome clustering in PP2A-Aα P179R/+ cells, the phenotype likely also arises from mechanisms unrelated to cell shape.
Discussion
Here we have characterized a cancer-associated hotspot P179R mutation in PP2A-Aα that allows cells to more efficiently cluster supernumerary centrosomes. This finding is important because cells with supernumerary centrosomes only survive mitosis if they cluster centrosomes (Ganem et al., 2009) . Our data suggests that a potential explanation for enrichment of PP2A-Aα mutations in tumors that experience WGD is to allow cells to survive the mitotic stress associated with centrosome amplification. PP2Adependent dephosphorylation has myriad roles in cell proliferation, and our work points to a change in phospho-signaling that enables more robust centrosome clustering.
Future work will be required to determine if there are additional impacts of hotspot mutations in the context of WGD, such as a compromised phospho-regulation of the G1/S checkpoint, which would allow cells to more readily proliferate after WGD.
Our work underscores the importance of considering PP2A-Aα mutations in a context that closely resembles the genetic change in tumors. Our data suggest that the enhanced centrosome clustering efficiency arises from haploinsufficiency in PP2A-Aα function, consistent with the known tumor suppressor role of PP2A (Pallas et al., 1990; Suganuma et al., 1988) . If the primary impact of the mutation is to reduce PP2A-Aα functionality, then it is perhaps unexpected that hotspot missense mutations dominate the PPP2R1A mutational landscape rather than truncations. Several functions of PP2A-Aα remain in the P179R mutant, including association with the catalytic subunit and STRN regulatory subunits. Thus, the mutations may selectively impact the subset of PP2A holoenzymes with tumor suppressor functions.
Our work reveals that decreasing PP2A functionality increases centrosome clustering, opening new avenues of exploration to understand how cancer cells efficiently cluster centrosomes. Given that the only known function of PP2A is to dephosphorylate serine/threonine residues, our work indicates that fine-tuning phospho-regulation, in the form of a heterozygous PP2A-Aα mutation, allows a human cell to become more proficient at centrosome clustering without compromising mitotic fidelity. Because the mutation only partially reduces PP2A-Aα function, and a WT allele remains present in the cell, we predict that the observed phenotype is due to small changes in phosphorylation of substrates that control centrosome clustering. Future work will focus on identifying these changes, including phosphorylation sites that impact centrosome positioning and engagement during mitosis. Lastly, pharmacologic activators of PP2A have recently been described, and it will be important to investigate their anti-tumor efficacies in human cancers with specific oncogenic PP2A mutations (Ramaswamy et al., 2015) .
Materials and Methods
Cell culture
hTERT WT cells (a gift from Alexey Khodjakov) and WT derivative cell lines were grown at 37°C in a humidified atmosphere with 5% CO 2 in DMEM:F12 growth medium.
Human embryonic kidney 293-T cells (ATCC) and Human embryonic kidney 293 cells (ATCC) were grown in DMEM growth medium. All media were supplemented with 10% fetal bovine serum (VWR Life Science), penicillin-streptomycin (Gemini Bio-Products), non-essential amino acids (Life Technologies), and L-glutamine (Sigma-Aldrich). Cell lines were authenticated upon initial receipt and upon initial generation by Short Tandem Repeat analysis at the Integrated Genomics Operations at Memorial Sloan Kettering Cancer Center. Cell lines were also tested for mycoplasma contamination by the Antibody and Bioresource core facility at Memorial Sloan Kettering Cancer Center.
Cell line generation
To generate the PP2A-Aα P179R/+ WT cell lines, we used adeno-associated virusmediated gene targeting. Q5 High-Fidelity DNA polymerase (New England Biolabs) was used to amplify two homology arms spanning exons 5 and 6 of PPP2R1A and cloned into a bacterial artificial chromosome (Life Technologies). The homology arms were cloned into vector pNX (Papi et al., 2005) flanking a loxP-Neo R -loxP cassette. Sitedirected mutagenesis was used to introduce a C to G mutation at nucleotide 23280 in exon 5 of PPP2R1A. The PPP2R1A homology fragment was then cloned into pAAV (Berdougo et al., 2009) by NotI restriction enzyme digestion. Isolation of AAV particles, selection of stable transductants, and PCR screening were carried out as previously described (Berdougo et al., 2009) . We determined the PPP2R1A genotype in isolated clones by genomic PCR amplification of PPP2R1A followed by Sanger sequencing. We Fisher Scientific) for 1 week. Puromycin-resistant cells were then grown in Tetracyclinefree serum (Clontech) and transduced with pLVX-Tet-On-Advanced lentivirus followed by G418 selection (500 µg/mL, Thermo Fisher Scientific) for 1 week. For each PP2A-Aα genotype, we chose a clone that yielded centrosome amplification in 60% of cells after 48 h doxycycline treatment (1 µg/mL).
We generated cells with fluorescent H2B by lentiviral transduction. H2B-RFP (Addgene plasmid 26001) or H2B-GFP (Addgene plasmid 25999) plasmids were co-transfected with psPAX2 and pCMV-VSV-G into HEK 293T cells. Supernatants were filtered, mixed with polybrene (4 µg/mL) and applied to target cells. We generated cells expressing GFP-PP2Aα by retroviral transduction as in (Foley et al., 2011) using WT PP2A-Aα (Foley et al., 2011) or P179R and R183W mutants, which were cloned via site-directed mutagenesis.
Inhibitor treatments
Commercially available small molecules and chemical inhibitors were used as follows - 
Live-cell imaging
Live imaging was performed on a Nikon Eclipse TiE inverted microscope equipped with a PI Piezo stage controller and Nikon Perfect Focus. Cells were maintained at 37 °C and 5% CO 2 with a Stage Top Incubator with Flow Control and a Sub Stage Environmental Enclosure (Tokai Hit). Cells were imaged by DIC and fluorescence microscopy (GFP-Ex470 nm; Em522 nm or DsRed-Ex508 nm; Em620 nm). Images were acquired with a 20X or 40X objective and recorded on a deep-cooled, ultra-low noise sCMOS camera (Andor) at 16-bit depth using Elements software (Nikon). Image cropping was performed in Fiji (Schindelin et al., 2012) .
Immunofluorescence microscopy
For immunofluorescence microscopy of α-tubulin, C-Nap 1, and centrin-1, cells on coverslips were fixed in methanol at −20 °C for 10 min. For PP2A-Aα and B56α immunofluorescence, cells on coverslips were pre-extracted for 40 s at 37 °C in PEM buffer (100 mM K-PIPES pH 6.9, 10 mM EGTA, 1 mM MgCl 2 ) with 0.5% Triton X-100 and 4 M glycerol. Coverslips were then fixed in PEM buffer with 3.7% formaldehyde and 0.2% Triton X-100 for 5 min at 37 °C. Coverslips were washed in TBS + 0.1% Triton X-100, blocked in same buffer with 2% donkey serum (Jackson Immunoresearch Laboratories) for 30 min, and stained with primary antibody for 3 h at room temperature. 
Species
Antibodies
Primary antibodies were used at 1 µg/mL for immunofluorescence incubations and 0.1 µg/mL for western blotting incubations. 2-4 µg of IgG was used for immunoprecipitation.
Custom PP2A-Aα antibody was generated by immunizing rabbits with the peptide sequence of MAAADGDDSLY conjugated to matriculture Keyhole Limpet Hemocyanin (Thermo Scientific). Antigens were injected into New Zealand White rabbits using an institutionally approved protocol and animal-care facility (Pocono Rabbit Farm and Laboratory, Canadensis, PA). To purify peptide antibodies, antisera were diluted with 0.1 vol 10X PBS and incubated overnight with immunizing peptide covalently coupled to sulfo-link resin (Thermo Fisher Scientific). After washing with PBS, antibodies were eluted with 0.2 M glycine, pH 2.5 and subsequently neutralized with Tris pH 8.0, followed by dialysis into PBS. Custom GFP antibodies were raised against bacterially Biotechnology SC-126, clone DO-1), and C-Nap 1(a gift from Bryan Tsou).
Mutation analysis in PPP2R1A
PPP2R1A mutations were quantified from publicly available studies on cBioPortal (Cerami et al., 2012; Gao et al., 2013) as of May 2018.
Cell lysis, immunoprecipitation and phosphatase assays
Frozen cell pellets were suspended in buffer B (30 mM HEPES pH 7.8, 140 mM NaCl, 6 mM MgCl 2 , 5% glycerol) supplemented with 2 mM DTT, ProBlock Gold Mammalian Protease Inhibitor Cocktail (GoldBio Technology) and PhosSTOP (Roche) and maintained at 4 °C. Samples were lysed by nitrogen cavitation (Parr Instruments) for 5 min at 2,000 psi, and then centrifuged at 20,000 x g for 15 min. Proteins were immunoprecipitated with antibody bound to Protein A Dynabeads (ThermoFisher 
PP2A-Aα immunoprecipitation for SILAC mass spectrometry analysis
Wild type RPE-1 cells expressing GFP-PP2A-Aα (WT, P179R, or R183W) were grown in DMEM:F-12 (1:1) media for SILAC (ThermoFisher Scientific), supplemented with 10% dialyzed FBS (ThermoFisher Scientific), 1X penicillin-streptomycin (Gemini Bio-Products), 2.5 mM L-Glutamine (Sigma-Aldrich), 0.175 mM Arginine and 0.25 mM Lysine. Arg 0 and Lys 0 amino acids were purchased from Sigma. Arg 10 ( 13 C 6 / 15 N 4 arginine) and Lys 8 ( 13 C 6 / 15 N 2 lysine) amino acids were purchased from Cambridge Isotopes. After two weeks of passaging, incorporation of heavy amino acids was measured by mass spectrometry. Samples with 95% or greater incorporation of Lys 8 and Arg 10 were used in analyses. For immunoprecipitation, asynchronously growing cells were trypsinized, pelleted, and frozen. Cells were thawed and re-suspended in lysis buffer (180 mM NaCl, 50 mM sodium phosphate pH 7.4, 2 mM MgCl 2 , 0.1% Tween-20, 1X ProBlock Gold Mammalian Protease Inhibitor Cocktail (GoldBio Technology) and 1X Simple Stop 3 phosphatase inhibitor (GoldBio Technology)). All further steps were carried out at 4 °C. Cells were lysed by nitrogen cavitation (Parr Instruments) at 2,000 psi for 10 min, followed by centrifugation at 20,000 x g for 20 min.
The supernatant was centrifuged once more. 5 mg protein was incubated with 125 µg α-GFP antibody covalently coupled to M270 magnetic resin (ThermoFisher Scientific) for 1 h with rotation. The resin was washed five times with lysis buffer. Bound proteins were eluted into 0.5 N NH 4 OH, 0.5 mM EDTA and dehydrated in a vacufuge (Eppendorf).
Dehydrated samples were suspended in 20 µL of NuPAGE LDS sample buffer (ThermoFisher Scientific). SILAC pairs were mixed, denatured at 90 °C for 2 min and separated on a 10% NuPAGE gel (ThermoFisher Scientific) at 120 V for 20 min. The gel was washed and silver stained (Pierce Silver Stain kit). Each lane was excised and destained using 30 mM potassium hexa-cyanoferrate (III) /100 mM sodium thiosulfate, washed and de-hydrated using a vacuum centrifuge. Proteins in the gel slabs were reduced, alkylated with iodoacetamide, dehydrated in a vacuum centrifuge. Gel slabs were then re-hydrated using 50 mM ammonium bicarbonate pH 8.4 (containing 0.04 µg sequencing grade modified porcine trypsin (Promega)) and incubated for 16 h at 37 ○ C.
After proteolysis inhibition and tryptic peptide elution from the polyacrylamide slabs, eluates from each lane were pooled, lyophilized, and stored at −80 ○ C until analysis.
The lyophilized peptide pellets were resuspended in 0.1% formic acid/ 3% acetonitrile and 5% of the solution was analyzed by LC/MS. 
